Supply Chain
India's largest drug manufacturer, Ranbaxy Laboratories and its U.S. subsidiary, Ranbaxy Inc., and the U.S. Justice Department, and U.S. Food and Drug Administration have reached an agreement over allegations that the company was selling potentially unsafe drugs in the United States.
UPMC attempts to reduce supply chain expenses by using an electronic data interchange.
Genetic and genomic clinical laboratory testing generates 116,000 U.S. jobs and contributes $16.5 billion annually to the U.S. economy, according to a new report released Thursday by the Battelle Memorial Institute.
The market for stem cell technologies will rise to over $700 million this year, and given some positive trends, could reach over $1 billion, according to healthcare market research publisher Kalorama Information.
The U.S. market for orthopedic biomaterials will grow at an average of just under 7 percent per year, to total approximately $4 billion by 2016, predicts medical technology market research firm Millennium Research Group (MRG).
Contrary to federal law, CMS accepted $15.1 million in gross drug costs for prescriptions written by excluded providers from 2006 to 2008 under the Medicare Part D program, according to a recent report from the Office of Inspector General.
The U.S. Department of Justice announced late last week that GE Healthcare has paid more than $30 million to the government to settle False Claims Act allegations.
As drug shortages become more frequent and severe, providers are feeling the financial impact of the higher-priced alternatives and the personnel hours required to deal with the escalating problem.
Even though the Centers for Medicare & Medicaid Services has taken steps to curtail fraud and abuse from Medicare suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), it needs to do more says a recently released report from the Office of Inspector General.
Healthcare real estate will continue to be a strong investment category in 2012 concludes an analysis by Jones Lang LaSalle, a financial and professional services firm specializing in real estate.